Prescribers had a more even split as to which GLP1-Agonist they preferred than non-prescribers
It is also important to note that these medications are not recommended for individuals with certain medical histories related to thyroid cancer
The decision memorandum Resolution of Semaglutide Injection Product Shortage and Supply Status, dated February 21, 2025, sets forth the FDAs full legal analysis upon which the February Declaratory Order is based.[ix] The FDA acknowledged that it has received reports that some patients and pharmacists are not able to obtain the semaglutide injection products through the normal supply chain
Semaglutide is administered as a once-weekly injection, starting with a low dose and gradually increasing over several weeks
Covering a six-year period of treatment, the study included 710 patients with type 2 diabetes, with 194 prescribed semaglutide
While switching delivery methods is unlikely to overcome a physiological plateau on its own, it can be one piece of a broader adjustment strategy